The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor

Mobilized blood has supplanted bone marrow (BM) as the primary source of hematopoietic stem cells for autologous and allogeneic stem cell transplantation. Pharmacologically enforced egress of hematopoietic stem cells from BM, or mobilization, has been achieved by directly or indirectly targeting the...

Descripción completa

Detalles Bibliográficos
Autores principales: Karpova, D, Dauber, K, Spohn, G, Chudziak, D, Wiercinska, E, Schulz, M, Pettit, A R, Levesque, J P, Romagnoli, B, Patel, K, Chevalier, E, Dembowsky, K, Bonig, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3865534/
https://www.ncbi.nlm.nih.gov/pubmed/24072044
http://dx.doi.org/10.1038/leu.2013.266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3865534/
https://www.ncbi.nlm.nih.gov/pubmed/24072044
http://dx.doi.org/10.1038/leu.2013.266

Ejemplares similares